India Glycols Limited has filed a regulatory disclosure under Regulation 30 of the SEBI Listing Regulations to intimate the schedule of upcoming analyst and institutional investor meetings.

The meeting schedule is as follows:

  • Monday, 28th September, 2026: Non-Deal meeting, In-Person mode, Singapore location
  • Tuesday, 29th September, 2026: Roadshow meeting

The company notes that changes may occur to the above meeting schedule due to exigencies on the part of participants, host, or the company itself.

Discussions during these interactions will be based exclusively on publicly available information. The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during these meetings.

This disclosure letter has been hosted on the company's website at www.indiaglycols.com.